CA1047923A - Method for producing a gamma-globulin solution suitable for intravenous application - Google Patents

Method for producing a gamma-globulin solution suitable for intravenous application

Info

Publication number
CA1047923A
CA1047923A CA260,555A CA260555A CA1047923A CA 1047923 A CA1047923 A CA 1047923A CA 260555 A CA260555 A CA 260555A CA 1047923 A CA1047923 A CA 1047923A
Authority
CA
Canada
Prior art keywords
gamma
globulin
acid ethyl
solution
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA260,555A
Other languages
English (en)
French (fr)
Inventor
Wolfgang Stephan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest Serum Institut GmbH
Original Assignee
Biotest Serum Institut GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19752539800 external-priority patent/DE2539800C3/de
Priority claimed from DE19762614503 external-priority patent/DE2614503A1/de
Application filed by Biotest Serum Institut GmbH filed Critical Biotest Serum Institut GmbH
Application granted granted Critical
Publication of CA1047923A publication Critical patent/CA1047923A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CA260,555A 1975-09-06 1976-09-03 Method for producing a gamma-globulin solution suitable for intravenous application Expired CA1047923A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19752539800 DE2539800C3 (de) 1975-09-06 1975-09-06 Verfahren zur Herstellung einer für die intravenöse Anwendung geeigneten Gammaglobulinlösung
DE19762614503 DE2614503A1 (de) 1976-04-03 1976-04-03 Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung

Publications (1)

Publication Number Publication Date
CA1047923A true CA1047923A (en) 1979-02-06

Family

ID=25769365

Family Applications (1)

Application Number Title Priority Date Filing Date
CA260,555A Expired CA1047923A (en) 1975-09-06 1976-09-03 Method for producing a gamma-globulin solution suitable for intravenous application

Country Status (8)

Country Link
US (1) US4154819A (https=)
JP (1) JPS5234918A (https=)
CA (1) CA1047923A (https=)
CH (1) CH597864A5 (https=)
FR (1) FR2322611A2 (https=)
GB (1) GB1528259A (https=)
NL (1) NL7609832A (https=)
SE (1) SE7609785L (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK139056B (da) * 1976-04-06 1978-12-11 Nordisk Insulinlab Fremgangsmåde til udvinding af immunoglobulin, der er egnet til intravenøs indgivelse.
DE2658334C3 (de) * 1976-12-23 1987-05-07 Behringwerke Ag, 3550 Marburg Verfahren zum Herstellen von Immunglobulinpräparationen mit verminderter Komplementaktivität und ein diese enthaltendes Arzneimittel
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
DE2829769C3 (de) * 1978-07-06 1982-10-14 Gruner + Jahr Ag & Co, 2210 Itzehoe Vorrichtung zum Heften mit metallischen Klammern
US4374763A (en) * 1979-09-17 1983-02-22 Morishita Pharmaceutical Co., Ltd. Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3916026A (en) * 1968-09-19 1975-10-28 Biotest Serum Institut Gmbh Method for the preparation of gamma-globulin suitable for intravenous use

Also Published As

Publication number Publication date
FR2322611A2 (fr) 1977-04-01
JPS5516565B2 (https=) 1980-05-02
CH597864A5 (https=) 1978-04-14
US4154819A (en) 1979-05-15
SE7609785L (sv) 1977-03-07
JPS5234918A (en) 1977-03-17
FR2322611B2 (https=) 1980-11-07
NL7609832A (nl) 1977-03-08
GB1528259A (en) 1978-10-11

Similar Documents

Publication Publication Date Title
CA1047923A (en) Method for producing a gamma-globulin solution suitable for intravenous application
KR0129539B1 (ko) 염기성 단백질이 함유된 혼합물로부터 염기성 단백질을 분리하는 방법
DE3888310T2 (de) Peptidderivate des Blutplättchen-Aggregations-Inhibitors.
DE68922358T2 (de) Chromatographische Trennung von Plasmaproteinen, insbesondere von Faktor VIII, von Willebrand Faktor, von Fibronectin und von Fibrinogen.
DE2417619C2 (de) Intramolekular vernetztes Hämoglobin, Verfahren zu dessen Herstellung und seine Verwendung
KR0161667B1 (ko) 헤파린 유도체 및 그 제조방법과 그를 함유하는 의약품
JPH02218696A (ja) 新規インシュリン誘導体、それらの使用およびそれらを含む医薬組成物
DE4435485C1 (de) Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
Rucinski et al. Human platelet factor 4 and its C-terminal peptides: heparin binding and clearance from the circulation
Hider et al. Lytic activity of monomeric and oligomeric melittin
EP0368486A2 (en) Novel inhibitors of platelet binding
US5872099A (en) High molecular and low molecular fractions of von Willebrand Factor
CZ286066B6 (cs) Způsob přípravy krystalického Lys B28 Pro B29-lidského inzulínu
US4164495A (en) Method of recovering immunoglobulin using a polyol and an alkanoic acid
CA1086648A (en) Method for preparation of antihemophilic factor
CA1137413A (en) Method for the production of immunoglobulin having a high monomer content
US6808706B1 (en) Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution
Lambert et al. Crystallization and preliminary X-ray diffraction studies of a complex between interleukin-2 and a soluble form of the p55 component of the high affinity interleukin-2 receptor
USRE31268E (en) Method of recovering immunoglobulin using a polyol and an alkanoic acid
US3856771A (en) Process for manufacturing alkali metal or ammonium insulin
EP0025321B1 (en) Composition containing s-sulfonated immunoglobulin and aggregation preventing or aggregate dissociating agent therefor, and processes for preparing compositions containing high proportions of monomeric s-sulfonated immunoglobulin
US5859213A (en) Aqueous β2'-glycoprotein I composition
Lee et al. Optical properties of an outer membrane lipoprotein from Escherichia coli
US4562152A (en) Process for obtaining pure L-leucine
Young The effects of maleylation on the properties of concanavalin A